Author

M. Rives

Observed names: M. L. Rives, M.L Rives, Marie-Laure Rives, Marie-Laure rives, Marie‐Laure Rives

Observed institutions: University of North Carolina at Chapel Hill, Centre National de la Recherche Scientifique, Inserm, Pfizer (United States), University of Toronto, Université de Montpellier, Columbia University Irving Medical Center, Structural Genomics Consortium, University of Mississippi, Ferring Pharmaceuticals (United States), Research Foundation For Mental Hygiene, Institut de Génomique Fonctionnelle, National Institute of Mental Health, Biosensing Instrument (United States), Université Montpellier 1, New York State Psychiatric Institute, Ferring Research Institute (United States), Janssen Research & Development (United States), Columbia University

ORCID: 0000-0003-3324-2412

Observed ORCID: 0000-0003-3324-2412

OpenAlex ID: A5050007556

Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization

2008 · Damien Maurel, Laëtitia Comps-Agrar, et al. · Nature Methods · 517

Time-resolved FRET between GPCR ligands reveals oligomers in native tissues

2010 · Laura Albizu, Martin Cottet, et al. · Nature Chemical Biology · 350

Detection of Antigen Interactions Ex Vivo by Proximity Ligation Assay: Endogenous Dopamine D2-Adenosine A2A Receptor Complexes in the Striatum

2011 · Pierre Trifilieff, Marie-Laure Rives, et al. · BioTechniques · 258

Identification of Novel Functionally Selective κ-Opioid Receptor Scaffolds

2013 · Kate L. White, Alex P. Scopton, et al. · Molecular Pharmacology · 146

PDF

Latest approaches for the treatment of obesity

2015 · V Margaret Jackson, Danna M Breen, et al. · Expert Opinion on Drug Discovery · 139

Crosstalk between GABAB and mGlu1a receptors reveals new insight into GPCR signal integration

2009 · Marie‐Laure Rives, Claire Vol, et al. · The EMBO Journal · 131

PDF

6′-Guanidinonaltrindole (6′-GNTI) Is a G Protein-biased κ-Opioid Receptor Agonist That Inhibits Arrestin Recruitment

2012 · Marie-Laure Rives, Mary Rossillo, et al. · Journal of Biological Chemistry · 116

Functional crosstalk between GPCRs: with or without oligomerization

2009 · Laurent Prezeau, Marie-Laure Rives, et al. · Current Opinion in Pharmacology · 112

Small Molecule Binding to Alzheimer Risk Factor CD33 Promotes Aβ Phagocytosis

2019 · Luke A. Miles, Stefan J. Hermans, et al. · iScience · 82

PDF

Potentiating SLC transporter activity: Emerging drug discovery opportunities

2017 · Marie-Laure Rives, Jonathan A. Javitch, et al. · Biochemical Pharmacology · 79

Discovery of a Novel Selective Kappa-Opioid Receptor Agonist Using Crystal Structure-Based Virtual Screening

2013 · Ana Negri, Marie-Laure Rives, et al. · Journal of Chemical Information and Modeling · 66

G‐protein‐coupled receptor oligomers: two or more for what? Lessons from mGlu and GABAB receptors

2009 · J.‐P. Pin, L. Comps‐Agrar, et al. · The Journal of Physiology · 61

Identification of highly selective SIK1/2 inhibitors that modulate innate immune activation and suppress intestinal inflammation

2023 · Holger Babbe, Thomas B. Sundberg, et al. · Proceedings of the National Academy of Sciences · 26

PDF

GPR40-Mediated Gα12 Activation by Allosteric Full Agonists Highly Efficacious at Potentiating Glucose-Stimulated Insulin Secretion in Human Islets

2018 · Marie-Laure Rives, Brian Rady, et al. · Molecular Pharmacology · 26

PDF

Identification of small-molecule protein–protein interaction inhibitors for NKG2D

2023 · Aaron A. Thompson, Michael B. Harbut, et al. · Proceedings of the National Academy of Sciences · 15

State-Dependent Allosteric Inhibition of the Human SLC13A5 Citrate Transporter by Hydroxysuccinic Acids, PF-06649298 and PF-06761281

2016 · Marie-Laure Rives, Morena Shaw, et al. · Molecular Pharmacology · 15

PDF

pH Dependence of a GPR4 Selective Antagonist Hampers Its Therapeutic Potential

2023 · Jacek Stalewski, Amy Y. Shih, et al. · Journal of Pharmacology and Experimental Therapeutics · 9

PDF

Design, synthesis and preclinical evaluation of bio-conjugated amylinomimetic peptides as long-acting amylin receptor agonists

2022 · Raymond J. Patch, Rui Zhang, et al. · European Journal of Medicinal Chemistry · 7

Time-resolved FRET approaches to study GPCR complexes

2010 · Jean Philippe Pin, Damien Maurel, et al. · Cambridge University Press eBooks · 5

A computational approach yields selective inhibitors of human excitatory amino acid transporter 2 (EAAT2)

2020 · Kelly L. Damm-Ganamet, Marie-Laure Rives, et al. · Journal of Biological Chemistry · 3

Development of small molecule inhibitors of natural killer group 2D receptor (NKG2D)

2023 · Jocelyn Wang, Kohki M. Nakafuku, et al. · Bioorganic & Medicinal Chemistry Letters · 2

Sensing conformational changes in metabotropic glutamate receptors

2013 · Marie-Laure Rives, Jonathan A. Javitch · Proceedings of the National Academy of Sciences · 2

Development of an oral small molecule protein-protein inhibitor of NKG2D with a novel SNAP-Tag cell-based assay

2024 · Heather Pascual, Brian Chiou, et al. · Journal of Pharmacology and Experimental Therapeutics

P-568 The effect of recombinant hCG on FSH-induced ovarian stimulation in rats depends on the FSH dose and can be detrimental at high concentrations

2022 · E Schoeller, S Jespersen, et al. · Human Reproduction

Chapter 12. Crosstalk Between Receptors: Challenges of Distinguishing Upstream from Downstream Mechanisms

2011 · Mahalaxmi Aburi, Marie-Laure Rives, et al. · RSC drug discovery/RSC drug discovery series

Works count: 26

Citation count: 2,167

H-index: 15

I10-index: 16